Melanoma vaccine could be available by 2025: Moderna CEO Ruchika Sharma17 Dec 2023 1:00 PM ISTWashington: Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two...
Japan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Ruchika Sharma14 Dec 2023 10:00 AM ISTLondon: GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a regulatory application to extend...
AstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion Ruchika Sharma12 Dec 2023 3:30 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company...
Pfizer, Valneva conclude recruitment for Phase 3 trial for Lyme Disease Vaccine candidate VLA15 Ruchika Sharma8 Dec 2023 2:30 PM ISTNew York: Pfizer Inc. and Valneva SE have announced that they have completed recruitment for the Phase 3 trial Vaccine Against Lyme for Outdoor...
Complications from flu largely preventable with annual flu vaccine Dr. Kamal Kant Kohli5 Dec 2023 11:00 PM ISTDuring National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if...
Maternal COVID-19 Vaccination Lowers risk of infection by omicron varient among infants: JAMA Jacinthlyn Sylvia4 Dec 2023 5:00 PM ISTIn a recent population-based cohort study Orlanda Goh and colleagues unveiled crucial insights into the impact of maternal mRNA vaccination on the...
Merck 21-valent Pneumococcal Conjugate Vaccine demonstrates superior immunogenicity for 10 of 11 Unique Serotypes compared to PCV20 in adults 50 years of age and older Ruchika Sharma30 Nov 2023 1:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced results from STRIDE-3, a Phase 3 trial evaluating V116, the...
Novavax updated COVID vaccine gets Emergency Use Listing from WHO Ruchika Sharma30 Nov 2023 11:30 AM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that Nuvaxovid XBB.1.5...
Updated adult immunization schedule for ages 19 years or older released by CDC Medha Baranwal23 Nov 2023 9:45 AM ISTUSA: The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has issued an updated version of the...
The BMJ study examines long-term effectiveness of live shingles vaccine Dr. Kamal Kant Kohli13 Nov 2023 9:45 AM ISTThe effectiveness of live zoster (shingles) vaccine is highest in the first year after vaccination and then wanes substantially. But it continues to...
Sanofi completes closing for potential vaccine against extraintestinal pathogenic E.coli Ruchika Sharma12 Nov 2023 5:00 PM ISTParis: Sanofi has announced the completion of closing for its collaborative agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson...
First Chikungunya Vaccine gets FDA nod Dr. Kamal Kant Kohli10 Nov 2023 5:07 PM ISTUSA: Ixchiq, the first chikungunya vaccine, has received approval from the U.S. Food and Drug Administration for individuals aged 18 years and above...
